ReviewPediatric radiology2026
Imaging assessment and interventional management of paediatric portal hypertension: an update.
Review in Pediatric radiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Portal hypertension in children presents distinct etiologies, clinical manifestations, and management strategies compared with adults, making accurate imaging evaluation essential across the diagnostic and therapeutic pathway. Ultrasound remains the first-line modality, providing real-time assessment of vascular anatomy, haemodynamics, splenic involvement, and portosystemic collaterals. Colour Doppler ultrasound and pulsed-wave Doppler ultrasound, along with systematic scanning protocols, enable early identification of portal vein obstruction, cavernous transformation, and hepatofugal flow patterns. Elastography techniques, particularly spleen stiffness measurement, provide valuable non-invasive biomarkers of clinically significant portal hypertension and variceal risk and complement conventional imaging. When ultrasound findings are inconclusive, contrast-enhanced ultrasound, computed tomography (CT), and magnetic resonance imaging (MRI) offer detailed vascular mapping, characterisation of parenchymal changes, and preoperative evaluation. MRI-especially dynamic contrast-enhanced sequences, magnetic resonance cholangiopancreatography (MRCP), and magnetic resonance elastography-provides comprehensive anatomical and functional assessment without ionising radiation. Interventional and surgical procedures, including portal vein recanalisation, Meso-Rex bypass, and transjugular intrahepatic portosystemic shunts, require precise imaging both before and after treatment. Long-term surveillance relies on multimodal imaging to detect stenosis, thrombosis, or flow-related complications and to guide timely reintervention. With continuous advances in elastography, high-resolution CT, and MRI-based haemodynamic techniques, imaging plays an expanding role in the tailored management of paediatric portal hypertension, supporting early diagnosis, therapeutic decision-making, and structured follow-up.
Indexed as
Identifiers
42423771What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.